- Home
- HOFT vs CNTB Comparison
HOFT vs CNTB Comparison
Compare HOFT & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HOFT | CNTB |
|---|---|---|
| Founded | 1924 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 144.6M | 135.7M |
| IPO Year | 1999 | 2020 |
Fundamental Metrics
Financial Performance| Metric | HOFT | CNTB |
|---|---|---|
| Price | $12.75 | $2.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.67 |
| AVG Volume (30 Days) | 35.1K | ★ 145.1K |
| Earning Date | 04-16-2026 | 08-13-2026 |
| Dividend Yield | ★ 3.79% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $278,139,000.00 | $64,000.00 |
| Revenue This Year | $17.37 | N/A |
| Revenue Next Year | $9.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.62 | $0.73 |
| 52 Week High | $15.99 | $3.82 |
Technical Indicators
Market Signals| Indicator | HOFT | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 45.05 | 44.75 |
| Support Level | $11.95 | $2.30 |
| Resistance Level | $13.49 | $2.67 |
| Average True Range (ATR) | 0.73 | 0.18 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 18.26 | 31.44 |
Price Performance
Historical ComparisonAbout HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.